Your browser doesn't support javascript.
loading
Absorption, distribution, metabolism, and excretion of [14C]Mefuparib (CVL218), a novel PARP1/2 inhibitor, in rats.
Li, Xin-Mei; Zheng, Yuan-Dong; Zhang, Yi-Fan; Huan, Xia-Juan; Yang, Chen; Liu, Meng-Ling; Shen, Xiao-Kun; Yang, Chun-Hao; Diao, Xing-Xing.
Afiliação
  • Li XM; Yunnan Provincial Key Laboratory of Pharmacology, Kunming Medical University, Kunming, 650000, China.
  • Zheng YD; Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201210, China.
  • Zhang YF; Department of Pharmacy, Fuwai Yunnan Cardiovascular Hospital, Kunming, 650000, China.
  • Huan XJ; Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201210, China.
  • Yang C; Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201210, China.
  • Liu ML; Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201210, China.
  • Shen XK; Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201210, China.
  • Yang CH; Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201210, China.
  • Diao XX; Convalife (Shanghai) Co., Ltd., Shanghai, 200000, China.
Cancer Chemother Pharmacol ; 90(6): 499-510, 2022 Dec.
Article em En | MEDLINE | ID: mdl-36283983
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Bile Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Bile Idioma: En Ano de publicação: 2022 Tipo de documento: Article